iShares US Aerospace & Defense ETF (ITA) Stock Price Today
BNP Paribas shares dip on French unrest fears but remain a buy due to strong fundamentals.
Shares of BNP Paribas have fallen about 10% amid concerns over French political unrest potentially impacting earnings and capital. However, the bank's French retail banking is a minor income source and benefits from structural strengths that can offs...
WPP remains a 'buy' with improving Q3 results and attractive valuation despite AI sector challenges
WPP is recommended as a 'buy' due to its attractive valuation amid skepticism about AI's impact on the sector. The company’s Q3 results showed a 0.5% revenue increase, disciplined cost management, and a £0.6bn reduction in net debt year-on-year. Whil...
Berkshire Hathaway rises 5% amid worst stock week since April 2025, holding $365B cash for buying opportunities.
During the worst stock market week since April 2025, Warren Buffett's Berkshire Hathaway shares rose 5.2%, reaching a record high while holding about $365 billion in cash. This cash reserve, about 29% of Berkshire's market value, allows the company t...
Axon cuts 2026 revenue forecast after $130M delay in Federal Dedrone deployments, shares drop.
Axon Enterprise lowered its 2026 revenue forecast to $3.61-$3.63 billion on November 5, removing about $130 million due to delays in three Federal Dedrone counter-drone deployments. This revision followed an August 5 forecast increase to 32%-34% grow...
Koppers shares drop after Q3 earnings miss and cut to 2026 guidance sparks investigation.
Koppers Holdings reported an 18% drop in adjusted EBITDA and a 38% decline in net income for Q3 2026, leading to a significant reduction in its full-year adjusted EPS guidance. This triggered a sharp decline in its stock price and prompted a legal in...
Madrigal Pharmaceuticals faces whistleblower claims, stock drops 8% amid alleged data suppression.
Madrigal Pharmaceuticals is under investigation after a whistleblower complaint from a former senior executive accused the company of suppressing adverse safety data and presenting unreliable efficacy results for its drug Rezdiffra. The allegations i...
DraftKings cuts 2026 revenue forecast, shares drop over 25% amid heavy Predictions investment
DraftKings lowered its full-year 2026 revenue guidance on November 6, 2026, to $6.35 billion-$6.55 billion, down from the previous $6.5 billion-$6.9 billion range set three months earlier. The revision is mainly due to increased investment in its Pre...
Datavault AI founder sues to overturn CEO removal amid $90M financing dispute
Nathaniel Bradley, founder of Datavault AI, filed a lawsuit to nullify his removal as CEO, alleging Board Chairman Brett Moyer illegally suspended him without a vote and concealed a $90–$100 million financing offer. Bradley claims the Board's actions...
Apple's iOS keyboard blocks autocomplete for 100,000+ words, including offensive and political phrases.
Researcher Derik Kauffman revealed that Apple's iOS keyboard uses a secret 'gray list' of over 100,000 words and phrases that it blocks from autocomplete and swipe-typing suggestions. The list includes vulgar, offensive, drug-related, and politically...
Interface cuts 2026 sales outlook, shares drop 20%, triggering securities law investigation.
Interface lowered its full-year 2026 sales forecast from $1.455-$1.485 billion to $1.440-$1.455 billion, causing its stock to fall over 20%. This change prompted an investigation into whether the company’s earlier sales outlook violated federal secur...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.